Trade Summary

5 months ago, Lynx1 Capital Management LP, serving as 10% owner at Passage Bio, Inc. (PASG), purchased 128,848 shares at $5.70 per share, for a total transaction value of $733,826.00. Following this transaction, Lynx1 Capital Management LP now holds 1,067,667 shares of PASG.

This purchase represents a 14.00% increase in Lynx1 Capital Management LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 22, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, July 24, 2025, 2 days after the trade was made.

Passage Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.